Advanced search×
×

Balancing health and industrial policy objectives in the pharmaceutical sector: Lessons from Australia

Health Policy 87(2):133 (2008) PMID 18295927

Introduction Policy-makers worldwide struggle to balance health with industrial policy objectives in the pharmaceutical sector. Tensions arise over pricing and reimbursement in particular. What health plans view as necessary to maintain equitable access to medicines, industry views as inimical to R&D and innovation. Australia has grappled with this issue for years, even incorporating the goal of “maintaining a responsible and viable medicines industry” into its National Medicines Policy.

DOI: 10.1016/j.healthpol.2008.01.003